Elkton, Virginia, October 21, 2025
Merck has announced a significant $3 billion expansion in Elkton, Virginia, which will create up to 500 new jobs in the Shenandoah Valley area. The new facility will focus on biopharmaceutical manufacturing, contributing to the national initiative to enhance domestic supply chains for essential medications. This investment not only aims to bolster the local economy but also aligns with efforts to ensure a steady supply of critical pharmaceuticals, reflecting Merck’s commitment to health and innovation in the region.
Elkton, Virginia
Merck & Co. has commenced construction on a $3 billion pharmaceutical manufacturing facility in Elkton, Virginia, aiming to create up to 500 new jobs in the Shenandoah Valley.
The 400,000-square-foot facility will serve as Merck’s Center of Excellence for Pharmaceutical Manufacturing, focusing on small-molecule production and testing. This expansion is part of Merck’s broader commitment to invest over $70 billion in U.S. manufacturing and research and development, enhancing domestic supply chains for critical medications.
Virginia Governor Glenn Youngkin highlighted the project’s significance, stating that it marks a substantial advancement for both America’s and Virginia’s life sciences sector. The expansion is expected to bolster the region’s economy and reinforce Virginia’s position as a leader in biopharmaceutical manufacturing.
Merck’s Elkton site has a longstanding history, with nearly 85 years of operations in the region. The new facility will complement existing operations, enhancing the production of small-molecule medicines and active pharmaceutical ingredients.
The Virginia Economic Development Partnership, along with local partners, played a crucial role in securing this project. To support the expansion, Governor Youngkin approved a $5 million performance-based grant from the Virginia Investment Performance program and a $4 million grant from the Commonwealth’s Opportunity Fund.
This development aligns with a nationwide trend of pharmaceutical companies increasing domestic manufacturing capabilities to strengthen supply chains and meet growing demand for critical medications.
FAQ
What is the purpose of Merck’s new $3 billion facility in Elkton, Virginia?
The facility will serve as Merck’s Center of Excellence for Pharmaceutical Manufacturing, focusing on small-molecule production and testing, and is expected to create up to 500 new jobs in the Shenandoah Valley.
How does this expansion impact Virginia’s economy?
The expansion is expected to bolster the region’s economy and reinforce Virginia’s position as a leader in biopharmaceutical manufacturing.
What is Merck’s broader investment plan in the U.S.?
Merck has committed to investing over $70 billion in U.S. manufacturing and research and development to enhance domestic supply chains for critical medications.
How long has Merck been operating in Elkton, Virginia?
Merck’s Elkton site has a longstanding history, with nearly 85 years of operations in the region.
What incentives has the Virginia government provided for this expansion?
Governor Youngkin approved a $5 million performance-based grant from the Virginia Investment Performance program and a $4 million grant from the Commonwealth’s Opportunity Fund to support the expansion.
Key Features of Merck’s $3 Billion Expansion in Elkton, Virginia
| Feature | Details |
|---|---|
| Investment Amount | $3 billion |
| Facility Size | 400,000 square feet |
| Job Creation | Up to 500 full-time positions |
| Governor’s Grants | $5 million from the Virginia Investment Performance program and $4 million from the Commonwealth’s Opportunity Fund |
| Merck’s U.S. Investment Plan | Over $70 billion in manufacturing and R&D |
Deeper Dive: News & Info About This Topic
HERE Resources
Construction Begins on Merck’s $3 Billion Pharmaceutical Facility in Virginia
Virginia Governor Celebrates Merck’s $3 Billion Investment
Merck & Co. Breaks Ground on Pharmaceutical Center in Virginia
Merck Expands Manufacturing Presence in Virginia
Virginia Welcomes Merck’s $3 Billion Investment in Elkton
Merck Unveils $70 Billion Manufacturing Initiative in Virginia
Merck Begins Construction of $3 Billion Pharmaceutical Plant in Virginia
Merck Breaks Ground on $3 Billion Manufacturing Site in Virginia
Merck Begins Construction on $3 Billion Manufacturing Facility in Virginia
Author: VIRGINIA STAFF WRITER
The VIRGINIA STAFF WRITER represents the experienced team at constructionvanews.com, your go-to source for actionable local news and information in Virginia and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as the Virginia Build Expo, major infrastructure projects, and advancements in construction technology showcases. Our coverage extends to key organizations like the Associated Builders and Contractors of Virginia and the Home Builders Association of Virginia, plus leading businesses in construction and legal services that power the local economy such as CMiC Global and Williams Mullen. As part of the broader network, including constructioncanews.com, constructionnynews.com, and constructiontxnews.com, we provide comprehensive, credible insights into the dynamic construction landscape across multiple states.
